-
-
Overview
-
dCBP-1 is a novel, potent and selective heterobifunctional and PROTAC degrader of p300/CBP with potential anticancer activity. It is highly potent at killing multiple myeloma cells and can abolish the enhancer that drives MYC oncogene expression.
Please contact us at for specific academic pricing.
-
- Properties
-
Overview